Stockreport

NEURELIS ENTERS $208 MILLION AGREEMENT TO MONETIZE INTRAVAIL ROYALTIES [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF SAN DIEGO Nov. 14, 2024 /PRNewswire/ -- Neurelis, Inc. ("Company"), today announced a transaction with OrbiMed for the sale of the Company's rights, royalty interests, [Read more]